A team tests the protective effect of a fermented black garlic extract against inflammation and the progression of prostate cancer in a study conducted on human prostate cancer cell models in the ...
Scientists have learned that prostate cancers can vary significantly among patients and that there are often differences within each patient's tumor. However, the study published Aug. 28 in Nature ...
A new study from Cold Spring Harbor Laboratory Professor Lloyd Trotman and colleagues, published in Science, shows that menadione significantly slows prostate cancer growth in mice and in ...
"Grey’s Anatomy" veteran James Pickens Jr. is opening up about his own real-life health diagnosis. Following the Thursday, Nov. 13 midseason finale episode, ABC aired a public service announcement ...
To understand how CDK12 loss impacts cells on a molecular level, researchers created a mouse model to try to parallel the genetic alterations they were seeing in human prostate cancers. What was quite ...
In a recent study published in the journal eBioMedicine, researchers attempted to identify, characterize, and quantify microplastics (including their abundances and types) found in human prostate ...
FORT MYERS, Fla., April 28, 2025 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) Director of Drug Development Manish Patel, MD, was the oral presenter of an abstract ...
A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene—commonly altered in prostate cancer ...
A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer. McGill University researchers at the Rosalind and Morris Goodman Cancer Institute (GCI ...
Pasritamig, a first-in-class bispecific T-cell-engaging antibody, shows potential in mCRPC with outpatient dosing designed for the community setting Data show low rates of treatment-related adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results